Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Aug 31, 2021 10:47am
132 Views
Post# 33787588

RE:RE:Fair value share price - $9.64

RE:RE:Fair value share price - $9.644real4ever:

Ya just can't fix stupid; you prove it with every asinine comment you post.

You do realise that the number $9.64 comes from a site that probably has even less knowledge of StageZero than you, and that's saying something. I am a long shareholder and I took it with a large grain of salt. But you swallowed it hook, line, and sinker, most likely because it suits your warped basher agenda. We have had estimates from other "experts" in the pennies to 14-$16(?) dollar range. Me, I will just wait for it to play out - patience is after all is a virtue.

I did not see anything in Photoman's post that he was even a shareholder let alone that he lost money in 2017, 2018, or 2019. Do you have any actual proof?

Oh, and for your Teddy(bear)3 tell him I am a shareholder not a StageZero employee. Now go give Teddy a big hug, it might make you both feel better.

As for the share price going down from $1.65 to where it is now it was a blessing in disguise for me and I suspect others; I increased my share holding by 300 percent, warrants by 250 percent. See how it works?  I guess the constant stream of tears in your eyes prevent you from seeing the obvious. 

Folks are laughing at you, not with you, give it up.
<< Previous
Bullboard Posts
Next >>